TriSalus Life Sciences, Inc. — Form D

TriSalus Life Sciences, Inc. of WESTMINSTER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-10. The offering totals $23.5M, of which $23.5M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Gene McGrevinDirectorWestminster, CO
Anil SinghalDirectorWestminster, CO
John L TullisDirectorWestminster, CO
Mats L WahlstromDirectorWestminster, CO
Raj L MistryExecutive OfficerWestminster, CO
James ChomasDirectorLongmont, CO
James ChomasExecutive OfficerLongmont, CO
Sean MurphyDirectorSan Diego, CA
Sean MurphyExecutive OfficerSan Diego, CA
DIANE PARKSDirectorSAN DIEGO, CA
Mary T SzelaDirectorWestminster, CO
Mary T SzelaExecutive OfficerWestminster, CO
Simone SongDirectorWESTMINSTER, CO
Kerry HicksDirectorWestminster, CO
Beverly L HussDirectorWestminster, CO
Simone R SongDirectorWestminster, CO
Anthony R ScaleseExecutive OfficerWestminster, CO
John R TullisDirectorWestminster, CO
Gene R McGrevinDirectorWestminster, CO
James E ChomasDirectorWestminster, CO
James E ChomasExecutive OfficerWestminster, CO
Karen J CassidyDirectorWestminster, CO
Karen J CassidyExecutive OfficerWestminster, CO
Ginger L GrahamDirectorWestminster, CO
Mats R WahlstromDirectorDenver, CO

Other filings by this issuer (7)

FiledFormOfferingSold
2022-11-10D$42.1M$15.3M
2022-11-10D$81.4M$81.4M
2017-03-07D$15.0M$12.9M
2015-11-05D/A$15.0M$15.0M
2015-06-23D$14.1M$11.0M
2013-09-16D$21.3M$16.4M
2011-04-26D$6.7M$3.7M

More